Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...

Gilead Sciences Inc. closed 0.11% below its 52-week high of $112.11, which the company reached on February 25th.

Oppenheimer raised the firm’s price target on Gilead (GILD) to $132 from $115 and keeps an Outperform rating on the shares. The firm says that ...

Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...

Hulu’s The Testaments casts its Daisy, a Canadian teen whose world is upended when she discovers her hidden connection to ...

The Handmaid’s Tale creator Bruce Miller has reportedly been working on the show for “several years” now, and stepped down as ...

Investors eyeing high-growth stocks should consider Corcept Therapeutics, TKO Group, and others with strong earnings ...

Hulu’s upcoming series “ The Testaments ,” a sequel to “The Handmaid’s Tale,” has cast Lucy Halliday in the role of Daisy.

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

Hulu confirmed Lucy Halliday will be appearing in The Testaments, The Handmaid's Tale sequel, and she is going to portray Daisy, the role of one of the trio of lead female characters in the series, Va ...

The Testaments, the sequel series to The Handmaid’s Tale, has cast a major leading role. The upcoming series, based on ...

The Leukemia & Lymphoma Society (LLS) has launched a new docuseries to inform blood cancer patients, caregivers, healthcare ...